ACS Nano · 2024 · 18 citations · 27 references
MedicineNeurosciencePharmacologyAgingDrug DeliveryNeuropharmacologyBlood-brain Barrier DeliveryBlood-brain Barrier PharmacologyDrug Delivery BiomaterialsLymphatic TransportNeurodegenerative Disease PharmacotherapyNeurodegenerative DiseasesAge-related Neurodegenerative MechanismsCerebral HomeostasisDeep Cervical Lymph NodesDeep Lymphatic SystemLong-acting Injectable ImplantsLymphatic Transport DysfunctionLymphatic Transport Of DrugsLyotropic Liquid Crystals
Numerous evidence has demonstrated that the brain is not an immune-privileged organ but possesses a whole set of lymphatic transport system, which facilitates the drainage of harmful waste from brains to maintain cerebral homeostasis. However, as individuals age, the shrinkage and dysfunction of meningeal and deep cervical lymphatic networks lead to reduced waste outflow and elevated neurotoxic molecules deposition, further inducing aging-associated cognitive decline, which act as one of the pathological mechanisms of Alzheimer's disease. Consequently, recovering the function of meningeal and deep cervical lymph node (dCLNs) networks (as an important part of the brain waste removal system (BWRS)) of aged brains might be a feasible strategy. Herein we showed that the drug brain-entering efficiency was highly related to administration routes (oral, subcutaneous, or dCLN delivery). Besides, by injecting a long-acting lyotropic liquid crystalline implant encapsulating cilostazol (an FDA-approved selective PDE-3 inhibitor) and donepezil hydrochloride (a commonly used symptomatic relief agent to inhibit acetylcholinesterase for Alzheimer's disease) near the deep cervical lymph nodes of aged mice (about 20 months), an increase of lymphatic vessel coverage in the nodes and meninges was observed, along with accelerated drainage of macromolecules from brains. Compared with daily oral delivery of cilostazol and donepezil hydrochloride, a single administered dual drugs-loaded long-acting implants releasing for more than one month not only elevated drug concentrations in brains, improved the clearing efficiency of brain macromolecules, reduced Aβ accumulation, enhanced cognitive functions of the aged mice, but improved patient compliance as well, which provided a clinically accessible therapeutic strategy toward aged Alzheimer's diseases.
27
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau, Igor Smirnov, Timothy Keyes et al. · Nature · 2015 · 4.3K citations
Medicine, Anatomy, Neurobiology +14
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Kwasi G. Mawuenyega, Wendy Sigurdson, Vitaliy Ovod et al. · Science · 2010 · 2.1K citations · Full text
Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease
Sandro Dá Mesquita, Antoine Louveau, Andrea Vaccari et al. · Nature · 2018 · 1.4K citations · Full text
Medicine, Neurology, Neuroscience +16
Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease
Constanze Depp, Ting Sun, Andrew Octavian Sasmita et al. · Nature · 2023 · 427 citations · Full text
Medicine, Neurology, Neuroscience +17